NEW YORK, May 2, 2018 /PRNewswire/ -- ExL Events is pleased to announce the inaugural TMF Institute — a landmarkeducation and professional growth opportunity for the life science industry. This event will take place on July 11–12, 2018, at the Colonnade Hotel in Boston.
A Trial Master File (TMF) is
The instruction of the institute's courses is based exclusively on what TMF professionals and stakeholders need to know and be able to do to excel within a particular area of responsibility as stewards, leaders, and architects of the TMF.
This is an unprecedented opportunity for professionals to expand their knowledge and enhance their competencies as clinical trial leaders. The TMF Institute incorporates what participants like most about the popular workshops we have offered at the TMF Summit Series' workshops into an objective-driven professional growth and learning opportunity.
Each of the following courses that comprise the TMF Institute are taught by a cadre of accomplished instructors and a lead teacher:
View the full brochure here.
The event is made possible in part because of its educational underwriters — Corementum, Just in Time GCP, Medidata, and the Health Sciences Records and Archives Association.
Register today and save 15% off standard registration rates with the Discount Code 792318PR.
ExL Events is the producer and host of a global series of TMF Summits which boasts the biggest TMF events in the US, Europe, and Asia. Through the TMF Institute, ExL Events is proud to continue our tradition of pioneering excellence in serving the needs of TMF professionals and stakeholders.
Contact: Camille Venturina, (917) 258-5158
View original content:http://www.prnewswire.com/news-releases/tmf-institute--courses-for-the-tmf-professional--july-1112-2018-boston-300641301.html
SOURCE ExL Events
Subscribe to our Free Newsletters!
Sleep paralysis is a condition where one feels unable to move (paralysis) or speak either when ...
Summers days are long, hot and sweaty, and can leave you feeling de-hydrated and tired. Read on to ...
Fosnetupitant and Palonosetron (a fixed antiemetic combination) injection was approved by FDA in ...View All